CIK 0001719406
- Non-accelerated filer
- Smaller reporting company
NRX Pharmaceuticals, Inc.
Sign in to watch- Ticker
- NRXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822844431
- Phone
- +1 484-254-6134
- Business address
- 1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
- Former names
- Big Rock Partners Acquisition Corp.
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4/A Returned to the company 10% owner returned 869,565 shares (to the company)
- 4 Conversion 10% owner acquired 27,250 shares (conversion)
- 4 Returned to the company 10% owner returned 869,565 shares (to the company)
- 4 Open-market sale 10% owner sold 29,464 shares at $10.60 ($312,318)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President and CEO sold 1,500,000 shares
- 4 Open-market buy President and CEO bought 22,500 shares at $10.00 ($225,000)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 4 of 5 · 84 filings